Maximising protection and value of your company’s biotechnology has become more and more complex as patent law continually evolves to keep pace with the rapid developments in biotechnology innovation. Ground-breaking case law decisions, legislative developments and evolving standards of the EPO and national patent offices mean that the rules of the game for qualifying for and defining the scope of your biotechnology patent are changing constantly and rapidly. The EPO rule changes will alter patent practice across Europe and affect existing and future European and PCT applications. Across the Atlantic, major policy and legislative developments and ground-breaking decisions from US courts redefine the standards for the patentability of biotech inventions.
In this fast changing high stakes industry it is imperative to have an up-to-the-minute, in-depth understanding of the decisions of the European and US courts and the very latest policies and practice of the EPO and USPTO.
Established among biotech practitioners as the market leading event, the 19th C5 Forum on Biotech Patenting will once again equip you with cutting edge information on the most pressing issues affecting biotech. Our outstanding panel of experts comprising influential regulators and experienced biotech patent counsel will share with you the latest strategies you can immediately incorporate into your practice, to optimally position yourself in offering your clients the most effective advice on obtaining, maximizing the scope of and safeguarding their biotech patent portfolio in today’s challenging conditions.
Confirmed speakers for 2010 already include:
The view from the bench on developments in biotech patenting litigation, a special address by
The Rt Hon Lord Justice Jacob, Court of Appeal of England and Wales
Back by popular demand
Aliki Nichogiannopoulou, Examiner-Biotechnology, European Patent Office
Plus
John Beatty, Patent Procedures Management, European Patent Office
Dr. Sjoerd Hoekstra, Director of one of the Biotechnology Departments, European Patent Office
Giampiero de Luca, Senior Executive Vice President, Licensing and Intellectual Property, Serono
Tony Rollins, Managing Counsel European Patents, Merck & Co.
Paul Commander, European Patent Attorney, Eli Lilly and Company Limited
Fiona Bor, Senior Patent Counsel, Teva Europe Patent Department
Tobias Roeser, German and European Patent Attorney, Sandoz AG
Marion Rees, IP Manager, Oxford Nanopore Technologies
Rob J. Aerts, Principal Patent Attorney, Abbott Healthcare Products B.V.
By attending, you will the most up-to-date information and insights on:
- The status and impact of major EPO and national court cases
- Recent changes in policy and patentability criteria: hear directly from the EPO and national patent offices
- Determine the latest strategies for adapting your patent practice to EPO rule changes
- European and US standards for Biosimilars: where do we stand and what does the future hold?
- Satisfying the requirements for industrial applicability following HGS . Eli Lilly
- The evolving landscape of Stem Cell Patentability in Europe
- A critical review on the availability of Supplementary Protection Certificates (SPCs) and
- Paediatric Extensions
- The scope of EU legislation on the protection of biotechnological inventions: a closer look at Monsanto v Cefetra and the biotech directive
- Drafting of Second Medical Use Claims after G2/08: how to ensure that your patent is likely to be valid
- Review major US Case Law and Policy Developments
C5’s Biotech Patenting Conference is the ONE place biotech patent practitioners come to learn and discuss the most recent and vital changes facing the industry today. You simply cannot afford to miss the ONE conference your colleagues –and competitors- attend year after year. Join us at the 19th C5 Forum on Biotech Patenting for an unparalleled learning and networking opportunity.
Don’t miss our practical and interactive workshops
Pre - Conference Workshop – Drafting Successful Patent Applications for Biotechnology Related Inventions – 5th October
Post – Conference Workshop – Managing Due Diligence: Scrutiny of Your Patent Portfolio – 8th October
3 easy ways to register:
1 . PHONE our registration hotline on +44 (0)20 7878 6888
2 . FAX your details directly to +44 (0)20 7878 6896
3 . EMAIL your details directly to Registrations@c5-online.com
Conference Details
